Biblio Discovery — Demo Discovery Service

304 hasil

Menampilkan 1–20 · 0,29 detik · RSS

Jurnal

European Cardiology Review

Scopus

ISSN 1758-3764 · Radcliffe Medical Media · 304 artikel di indeks

  1. Artikel Jurnal

    Commencement of Atorvastatin and Ezetimibe Immediately in Patients Presenting with Acute Coronary Syndrome

    Mohammed Sallam; Hossameldin Hassan; Derek Connolly dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Lipids are implicated in the development of coronary atherosclerosis. Achieving a significant reduction in lipid levels remains a crucial aspect of secondary prevention following an acute coronary syndrome event. Novel lipid-lowering therapies now provide clinicians with a variety of therapeutic…

  2. Artikel Jurnal

    Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice

    Andrea Di Lenarda; Nicola Ferri; Massimiliano Lanzafame dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Cardiovascular disease is associated with progression to severe COVID-19 and patients with the condition are among those in whom early antiviral therapy should be warranted. The combination of nirmatrelvir/ritonavir (Paxlovid®) has been approved for clinical use by the Food and Drug Administration…

  3. Artikel Jurnal

    Sex Difference in 5-year Relative Survival Following Percutaneous Coronary Intervention

    Jin-Ho Choi; Jung-Min Choi; Ki-Hong Choi dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Background: Survival rates following percutaneous coronary intervention (PCI) show variability across studies, particularly regarding sex-specific outcomes. Relative survival analysis, which considers survival patterns in sex- and age-matched general populations, could help explain this…

  4. Artikel Jurnal

    Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome

    Sheila Gato; Vanessa García-Fernández; Antonio Gil-Gómez dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    The global prevalence of non-alcoholic fatty liver disease (NAFLD) is nearly 25% and is increasing rapidly. The spectrum of liver damage in NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis, characterised by the presence of lobular inflammation and hepatocyte ballooning…

  5. Artikel Jurnal

    The Need for Separate Testing with Acetylcholine for the Assessment of Endothelial Dysfunction and Coronary Artery Spasm

    Shozo Sueda; Tomoki Sakaue

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Intracoronary acetylcholine (ACH) testing is clinically useful to diagnose the presence of the coronary vasomotor disorders coronary endothelial dysfunction and coronary epicardial/microvascular spasm. In Western countries, continuous intracoronary injection of ACH for 2–3 minutes without a…

  6. Artikel Jurnal

    Staging Heart Failure with Preserved Ejection Fraction by Assessing Cardiac Chamber Involvement

    Anastasia Shchendrygina; Ilya Giverts; Mariya Tokmakova dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    The management of heart failure with preserved ejection fraction (HFpEF) remains largely unresolved due to our limited understanding of the underlying mechanisms of the pathology and the challenges in accurately phenotyping this heterogeneous syndrome. A paradigm shift is required to personalise…

  7. Artikel Jurnal

    Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting

    Paula Luque-Linero; Luis Castilla-Guerra

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Non-alcoholic fatty liver disease (NAFLD) is an overlooked and undetected pathology, which affects more than 32% of adults worldwide. NAFLD is becoming more common in Western industrialised countries, particularly in patients with central obesity, type 2 diabetes, dyslipidaemia and metabolic…

  8. Artikel Jurnal

    Diagnostic Yield of Comprehensive Coronary Function Testing in Patients with Angina and Unobstructed Coronary Arteries: Endotype Characterisation and Clinical Implications

    Johanna McChord; Astrid Hubert; Raffi Bekeredjian dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Background: Coronary functional disorders (CFD) are significant contributors to angina with non-obstructed coronary arteries (ANOCA). Various endotypes, such as epicardial or microvascular spasm and/or coronary microvascular dysfunction (CMD), have been identified. Previous studies have shown a…

  9. Artikel Jurnal

    What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?

    Maki Komiyama; Moritake Iguchi; Hiromichi Wada dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Factor XIa (FXIa) may be involved in thrombus formation, but only to a lesser extent involved in haemostasis. Several novel FXIa inhibitors are under investigation, and Phase II trials demonstrated marked reduction of bleeding compared with standard treatment by factor Xa inhibitors. Asundexian is…

  10. Artikel Jurnal

    Unusual Presentations of Thyrotoxic Tricuspid and Mitral Regurgitations in 62 Adults: A Systematic Review of Case Reports with In-depth Pathophysiological Review

    Andro Pramana Witarto; Bendix Samarta Witarto; Shidi Laras Pramudito dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Background: Thyrotoxicosis is related to cardiovascular mortality. This can be caused by several clinical manifestations involving the rare provocation of tricuspid regurgitation (TR) and mitral regurgitation (MR). However, there are still no clear data on thyrotoxic TR and/or MR. This study…

  11. Artikel Jurnal

    Symptomology, Outcomes and Risk Factors of Acute Coronary Syndrome Presentations without Cardiac Chest Pain: A Scoping Review

    Meriem Perona; Amanda Cooklin; Christopher Thorpe dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    For patients experiencing acute coronary syndrome, early symptom recognition is paramount; this is challenging without chest pain presentation. The aims of this scoping review were to collate definitions, proportions, symptoms, risk factors and outcomes for presentations without cardiac chest pain…

  12. Artikel Jurnal

    Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis

    Dirk Sibbing; Michael J Blaha; Rajinder Chawla dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Background: Low-dose aspirin lowers cardiovascular event risk; dual-pathway inhibition (DPI) using low-dose aspirin with low-dose rivaroxaban may reduce this risk further. A systematic literature review and meta-analysis compared the efficacy, safety and net clinical benefit (NCB) of DPI with…

  13. Artikel Jurnal

    Levosimendan, a Promising Pharmacotherapy in Cardiogenic Shock: A Comprehensive Review

    Hendri Susilo; Fan Maitri Aldian; Citrawati Dyah Kencono Wungu dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Cardiogenic shock (CS) is a critical condition with high mortality rate, as the current management of CS presents significant challenges. Exploration of more effective therapies is necessitated. This review article comprehensively examines the efficacy and safety of levosimendan in the management…

  14. Artikel Jurnal

    The Global Burden of Resistant Hypertension and Potential Treatment Options

    Giacomo Buso; Claudia Agabiti-Rosei; Matteo Lemoli dkk.

    European Cardiology Review, Vol. 19 · 2024 · Inggris · DOAJ Scopus

    Resistant hypertension (RH) is defined as systolic blood pressure (SBP) or diastolic blood pressure (DBP) that remains ≥140 mmHg or ≥90 mmHg, respectively, despite an appropriate lifestyle and the use of optimal or maximally tolerated doses of a three-drug combination, including a diuretic. This…